November 2, 2020

Isofol announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada

Link to the press release >>

A milestone is reached with the inclusion
of 330 patients in the AGENT study
– opening up for the interim analysis


See how arfolitixorin
works in cancer cells

See the animation >>



Startpage 2

Upcoming Events

  • November 26, 2020 - November 26, 2020
    RedEye: Life Science Day
    Isofol will attend at Redeye´s event "Life Science Day" in Stockholm. Isofol´s CEO will be presenting at 11.10 (CET) and the seminar will also be broadcast live.
  • December 15, 2020 - December 15, 2020
    DNB Healthcare Conference 2020
    Isofol will participate in this virtual conference hosted by Den Norske Bank. The conference consists of two sessions: DNB Markets Session and DNB NXT Healthcare Venture Session. Isofol will present at 10.15 (CET).